Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132052 · ClinicalTrials.gov registry record
Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 81
- Enrollment target
NCT02132052 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 81 participants.
The verdict
NCT02132052 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
Investigators hypothesize that there are specific characteristic of each cognitive and motor condition that can be defined using brains scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132052
The ClinicalTrials.gov registry entry for NCT02132052 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02132052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02132052 about?
NCT02132052 is a clinical study titled "Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.". Investigators hypothesize that there are specific characteristic of each cognitive and motor condition that can be defined using brains scans.
What is the current status of trial NCT02132052?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2013-11. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT02132052?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.